1. Treatment of Diabetes with Chinese and Western Medicine, Luo Qingbo, Hong Kong, Medicine Expo, 1995,1,2,38-39.

Articles published in domestic public publications (2 articles)

Scientific research papers (2)

Determination of sorbitol and mannitol in sorbitol aqueous solution by HPLC, Luo Qingbo, Journal of Analysis and Testing, 1993, 12, No.4-73-75.

2. Determination of silicon content in steel by fluorine electrode method, Deng Mingtao, Luo Qingbo, Journal of Chengdu Institute of Science and Technology,1993,5,43-45.

Industry research (16 articles)

1. Present situation and future of soft capsule preparations in China, Luo Qingbo, Shanghai Medical Information Research, 1995, 1-13- 14.

2. Deciphering the password of pharmaceutical market, Zhang, Luo Qingbo, Pharmaceutical Economy, 1997, 3 -4 1-42.

3. Perspective on the loss of foreign-funded pharmaceutical enterprises, Luo Qingbo, Pharmaceutical Economy,1994,2-30-31No./Shanghai Pharmaceutical1994,07/China Pharmaceutical 19606.

4. Implementation of OTC system: All sectors of society should cooperate with Qi Xin, Luo Qingbo, Pharmaceutical Economy, 1997, No.5-27-29/chinese pharmaceutical affairs 1990 1.

5. Reasons for the decline of China's chemical exports and countermeasures, Luo Qingbo, China Medical Information, 1997, Vol.3, No.6 -37 1-372.

6. The market management of codeine preparations needs to be strengthened, Luo Qingbo, China Pharmaceutical,1998,08.

7. Preparation Export: Special Topics on Foreign Trade of Medicine and Health Products, Qingbo, China Medicine,1994,2, 17- 18.

8. The development prospect of chemical and pharmaceutical intermediates in China is broad, Luo Qingbo, China Chemical Industry, 1996.053-54.

9. Who is the chief culprit of drug price increase? Luo Qingbo, China Pharmaceutical, 1995/07.

10. China's countermeasures to open up the international Chinese medicine market, Luo Qingbo, China Journal of Chinese Medicine Information,1994,03.

1 1. to speed up imitation and innovation, Luo qingbo, medical economic news, 2002-05-08.

12. Dispel the shadow in the research and development of new drugs. Frankly speaking, China Pharmaceutical, 1999/07.

13. Problems and solutions of new preparations, Luo Qingbo, pharmaceutical economy, 1997, 0 1, P30-3 1.

14. Functional health food has development value, Luo Qingbo, medical information, 1997/03.

15. Five trends of Chinese patent medicine market, Qingbo, Journal of Medical Forum, 1993, 0 1.

16. The pace of shareholding system reform in China pharmaceutical industry has been steadily accelerated, and Shanghai Pharmaceutical,1994,02.

Variety analysis (40 articles)

1. analysis and countermeasures of clindamycin domestic market, Luo qingbo, medical information, 1994, 6: 7- 10.

2. Polymer: the culprit of sensitization to β -lactam antibiotics, Luo Qingbo, Journal of Medical Economics. 1997.438+02. 18.6.

3. Development status of new anticancer drugs, Luo Qingbo, China Journal of New Drugs,1999,5,339-342.

4. Discussion on the market, production and marketing of vitamin E, Luo Qingbo, Medical Information, 1994, 5:26-28.

5. The price of oxalic acid is tight, Luo Qingbo; Shanghai medicine; 1995 1 1; 36

6. China vitamin C dominates the US market, Luo Qingbo; Shanghai medicine; 1994 09; 46-47

7. Research and development status and development suggestions of fluoroquinolones in China, Luo Qingbo et al., China Medical Information, 2002, 18, No.3-20-23.

8. Present situation, existing problems and countermeasures of VC production and marketing in China, Luo Qingbo, China Medical Information, 1998, Vol.4, No.2-93-93.

9. Production and marketing status of starch and its derivatives in China, Luo Qingbo, Yun Jiangang, China Medical Information, 1997, Vol.3, No.3-16 1- 163.

10. Introduction of anticancer drugs developed in China in recent years, Luo Qingbo, China Medical Information, 1996, Vol.2, No.4 -246-248.

1 1. the present situation and future of norfloxacin in China, Luo qingbo, chemical and pharmaceutical industry information,11vol. 4 -4-8.

12. overview of the world sorbitol market, Luo qingbo, China medical information, 1995, vol. 1, No.2-93-95.

13. Market analysis and development suggestions of diabetes drugs in China, Luo Qingbo, information of chemical and pharmaceutical industry, 1994,1-36-39, medical economic information,1994,21.

14. Discussion on the market and production of vitamin E, Luo Qingbo, Medical Information, 1994, No.5-26-28.

15. Problems of antibiotic production and marketing in China and development countermeasures, Luo Qingbo, medical information, 1994, No.2-45-49.

16. technical level and development suggestions of sorbitol production, Luo qingbo, scientific information of chemical products, 1994, 17, vol. 2 -3-7.

17. the development prospect of vitamin e, Luo qingbo, Shanghai medical information research, 1994, No.4-3-5.

18. How do antibiotics meet the challenge of "returning"? , Luo Qingbo, Shanghai Medical Information Research,19941-14-18.

19. Xanthan gum has an attractive development and production prospect, Luo Qingbo, Shanghai Medical Information Research, 1994 1 -63-65.

20. Development status and development trend of new vitamin C products, Medical Information, 1993, No.3-53-57.

2 1. Problems and development countermeasures of sorbitol production in China, Luo Qingbo, medical information, 1993, 1 -24-29.

22. New Drugs Listed in Japan, translated by Luo Qingbo, Chemical Pharmaceutical Industry Information, 1992, No.6-35-37.

23. Discussion on the improvement of VC quality testing method, Luo Qingbo, Information of Chemical and Pharmaceutical Industry, 1992, No.2-25-26.

24. Current situation and trend of new product development of vitamin C, Luo Qingbo, Henan pharmaceutical industry, 1994, No.3, 17-2 1.

25. Use and production of modified starch, Luo Qingbo, Zhongzhou Food Science and Technology,1992,2,21-22.

26. paracetamol market analysis and suggestions for the development of China, Luo Qingbo, China Medical Information, 1996, Vol.2, No.5 -286-286.

27. There are five major trends in the penicillin market, Qingbo, Information of Chemical and Pharmaceutical Industry,19951volume 10-19-20.

28. Vitamin E, Qingbo, Chemical and Pharmaceutical Industry Information, 1994, 10, 13- 16 Market Analysis and Development Suggestions.

29. Application of Cyclodextrin in Pharmaceutical Industry, Luo Qingbo, Pharmaceutical Economic Information, 1997,12,5-6.

30. Production and marketing status of xanthan gum at home and abroad and suggestions for China's development, Luo Qingbo, medical and economic information, 1994, 16, 1-3.

3 1. Analysis on the development of antifungal drugs at home and abroad, Luo Qingbo, medical and economic information,1998,6,4-5.

32. Production and marketing status of nicotinic acid at home and abroad, Luo Qingbo, medical economic information, 1996,14,2-3.

33. What makes erythromycin popular? Luo Zhongyuan, China Pharmaceutical, 1994, 09, 29-30.

34. Giant Buddha Throat Dew Spray, Luo Qingbo, China Journal of New Drugs, 1996/02.

35. The Rise and Fall of the Class Star of Ofloxacin, Luo Qingbo, Medical Economic News, 2002-05-0 1.

36. Technical level and development trend of sodium D-isoascorbate, Luo Qingbo, Shanghai Medical Information Research,1994,03.

37. Polymers: A New Project for Quality Control of β -lactam Antibiotics, Luo Qingbo, Antibiotic Newsletter.5438+0997.438+00,5-7.

38. Analysis of domestic and international production and marketing situation of cefaclor, Luo Qingbo, antibiotic newsletter. 1997. 10, 17- 18.

39. Ciprofloxacin: Is it spicy? Qingbo, China Pharmaceutical, 1994,10,38-39.

40. The reasons and development trend of erythromycin epidemic, Luo Qingbo, China Medicine Collection,1994,3, 16- 17.

News reports (3 articles)

1. Serve the country conscientiously ── Interview with Mr. Cai and his "Federal Pharmaceutical", Luo Qingbo, China Pharmaceutical,1997,07.

2. The story of Zhou Hailong, deputy general manager of the ancient city star Henan Kangtai Pharmaceutical Group Co., Ltd., developing norfloxacin, Qingbo, Henan Science and Technology, 1999/0 1.

3. A Le regulates your blood lipid, Ronin, Medicine World, 2000/07.

Articles on domestic industry conferences (2 articles)

1. Current research and development status and market development trend of cold medicine preparations, Luo Qingbo, 2001.3.16-18, national seminar on development and rational application of cold medicine preparations, sponsored by Beijing International Conference Center and Medical and Health Science and Technology Development Research Center of Ministry of Health.

2. Culture, resources and science and technology: three major themes of the development of traditional Chinese medicine after China's entry into WTO, Luo Qingbo, etc., China Symposium on the Development of Traditional Chinese Medicine, 200 1, Beijing, P58 1-584.

Internal journals of enterprises (4 articles)

1, polymer: the culprit of β -lactam antibiotics sensitization, Luo Qingbo, Federal Medical Newsletter,1994,04, 16-20.

2. Grasp today and embrace glory, Luo Qingbo, Honghui Pharmaceutical 2000, July and April, P48-49.

3. Effects of Several HMG-COA Hypolipidemic Drugs, Luo Qingbo, Honghui Pharmaceutical, July 4, 2000, P 16- 19.

4. Cold medicine: How many markets can you win? Luo Qingbo, Honghui Pharmaceutical, 200 1, 02, P29-34.